I’ve partnered with Seed because I strongly believe in the company’s transparent and evidence-based approach to develop their flagship DS-01TM Daily Synbiotic—a combination of 24 clinically and scientifically-studied validated probiotic strains and a novel non-fermenting prebiotic, punicalagin, sourced from Indian Pomegranate. The DS-01TM was formulated for benefits in and beyond the gut—supporting digestive health, gut immune function, gut barrier integrity, skin health, cardiovascular health, and micronutrient synthesis. Several high-quality clinical trials with prestigious academic partners are underway to generate additional data related to IBS symptomology and post-antibiotic recovery. Seed is not only committed to transparency, education, and evidence-based information regarding its products, but the overall goal of the company is to pioneer applications of microbes to support the One Health concept with health benefits that consider both humans and the planet.
Disclosure: I am a member of the Scientific Advisory board for Seed Health.